SCHEMBL4839397

SCHEMBL4839397

O=C(NC(CCNc1ncnc2cc(C(=O)N3CC=CC3)c(Cl)cc12)c1nc2cc(Cl)ccc2[nH]1)OCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 3/20 0.41
HDAC4 P56524 3/20 0.41
HDAC1 Q13547 3/20 0.41
HDAC7 Q8WUI4 3/20 0.41
HDAC2 Q92769 3/20 0.41
HDAC10 Q969S8 3/20 0.41
HDAC11 Q96DB2 3/20 0.41
HDAC8 Q9BY41 3/20 0.41
HDAC6 Q9UBN7 3/20 0.41
HDAC9 Q9UKV0 3/20 0.41
HDAC5 Q9UQL6 3/20 0.41
AAK1 Q2M2I8 6/20 0.40
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
CTDSP1 Q9GZU7 1/20 0.36
ALDH1A1 P00352 2/20 0.35
LMNA P02545 2/20 0.35
PIK3CD O00329 2/20 0.34
PIK3R1 P27986 2/20 0.34
CNR1 P21554 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4150568 0.90 HDAC3 (0.36) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8325454 0.86 OPRM1 (0.34) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL4147775 0.85 OPRM1 (0.37) OPRM1OPRD1CTDSP1ALDH1A1LMNA
SCHEMBL13772360 0.85 OPRM1 (0.37) OPRM1OPRD1CTDSP1ALDH1A1LMNA
SCHEMBL4147777 0.85 OPRM1 (0.37) OPRM1OPRD1CTDSP1ALDH1A1LMNA
SCHEMBL6227800 0.85 AAK1 (0.40) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8317288 0.79 CNR1 (0.36) HDAC1HDAC8HDAC6OPRM1OPRD1
SCHEMBL2998638 0.79 OPRM1 (0.35) AAK1OPRM1OPRD1CTDSP1ALDH1A1
SCHEMBL2998637 0.79 OPRM1 (0.35) AAK1OPRM1OPRD1CTDSP1ALDH1A1
SCHEMBL3000212 0.79 RPS6KB1 (0.33) OPRM1OPRD1CTDSP1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429597-B2 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO., KG (DE) 2008-09-30 US disclosed
US-20040176603-A1 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176603-A1 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions F11, F12, F2 HDAC3 2759/4885HDAC4 4406/4885HDAC1 2030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.